Y-Intercept (HK)’s Boundless Bio BOLD Stock Holding History

Y-Intercept (HK)’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-55,242	Closed	-$55.8K	–	2134
2025 Q2	$55.8K	Buy	+55,242	New	+$73.4K	﹤0.01%	1554

Other funds holding BOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Y-Intercept (HK)'s BOLD Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Boundless Bio (BOLD) in Q3 2025, closing a stake of 55,242 shares — an estimated $55.8K sold.

Y-Intercept (HK) first reported a position in BOLD in Q2 2025 and held it in 1 quarter. The position peaked at $55.8K in Q2 2025. 35 funds tracked by Wall St. Rank hold BOLD as of Q3 2025.

Y-Intercept (HK) reported no remaining Boundless Bio position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 55,242 Boundless Bio shares in Q3 2025, an estimated $55.8K.
Y-Intercept (HK) first reported a position in Boundless Bio in Q2 2025 and held it in 1 quarter.
Y-Intercept (HK)'s Boundless Bio position peaked at $55.8K in Q2 2025.
35 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.